Jefferies Financial Group cut shares of Spire Healthcare Group (LON:SPI) to a hold rating in a research report sent to investors on Friday. They currently have GBX 160 ($2.04) price target on the stock, down from their previous price target of GBX 290 ($3.70).

A number of other research firms also recently issued reports on SPI. Liberum Capital reiterated a hold rating on shares of Spire Healthcare Group in a research report on Tuesday, July 17th. Peel Hunt reiterated an add rating on shares of Spire Healthcare Group in a research report on Tuesday, July 17th. JPMorgan Chase & Co. dropped their target price on shares of Spire Healthcare Group from GBX 293 ($3.74) to GBX 256 ($3.27) and set a neutral rating on the stock in a research report on Tuesday, August 7th. Berenberg Bank downgraded shares of Spire Healthcare Group to a sell rating and lowered their price objective for the stock from GBX 290 ($3.70) to GBX 120 ($1.53) in a report on Wednesday, August 8th. Finally, Credit Suisse Group upgraded shares of Spire Healthcare Group to a neutral rating and lowered their price objective for the stock from GBX 250 ($3.19) to GBX 215 ($2.74) in a report on Wednesday, August 8th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. Spire Healthcare Group has a consensus rating of Hold and a consensus price target of GBX 228.63 ($2.92).

Spire Healthcare Group stock opened at GBX 160.50 ($2.05) on Friday. Spire Healthcare Group has a 12-month low of GBX 206.40 ($2.63) and a 12-month high of GBX 362.10 ($4.62).

In other Spire Healthcare Group news, insider Peter R. Bamford acquired 4,000 shares of the stock in a transaction on Thursday, June 7th. The shares were purchased at an average price of GBX 248 ($3.16) per share, for a total transaction of £9,920 ($12,654.68). Also, insider Peter R. Bamford acquired 10,000 shares of the stock in a transaction on Thursday, August 9th. The shares were acquired at an average price of GBX 161 ($2.05) per share, for a total transaction of £16,100 ($20,538.33).

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

Featured Article: Short Selling Stocks, A Beginner’s Guide

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.